AI tool spots heart disease risk before symptoms start
Hidden heart disease in your records
Imagine walking into a doctor's office with a vague feeling of fatigue. You might feel tired or short of breath. These are common signs of many conditions. Doctors often miss the real cause until it is too late.
Cardiac amyloidosis is a rare heart condition. It happens when bad proteins build up in the heart muscle. This makes the heart stiff and weak. It can lead to heart failure if not treated.
Finding this disease early is very hard. The symptoms look like other common heart problems. Doctors usually wait for clear signs before ordering special tests. This delay can be dangerous for patients.
Why waiting for symptoms is dangerous
Waiting for symptoms to get worse is a risky strategy. By the time a patient feels sick, the heart may already be damaged. Early treatment can save lives and improve quality of life.
Current methods rely on doctors guessing who needs a test. They look at age and other risk factors. This approach misses many people who are actually at risk.
Many patients go undiagnosed for years. They suffer from symptoms that could have been managed better. The goal is to find these patients before they get sick.
The AI that spots the risk
A new tool called Amylo-Detect changes how doctors find this disease. It uses artificial intelligence to scan electronic health records. The system looks at fifty different data points from a patient file.
Think of it like a traffic jam detector. The AI watches for patterns that suggest a blockage is forming. It spots the risk before the traffic actually stops.
This tool looks at routine data like blood tests and past diagnoses. It does not need new scans or expensive equipment. It works with information doctors already have on file.
This does not mean you can use this tool at home.
The system was tested on thousands of patients in Austria and Germany. It looked at over eleven thousand people in Vienna alone. It also checked data from another hospital in Essen.
The AI predicted who would have high-grade uptake on a scan. It matched the results of a specialized bone scan very well. The model worked better than standard scoring systems used by doctors.
But the tool is not a diagnosis
The AI found patients that routine checks missed. About ten percent of patients with the disease were overlooked by standard care. The tool caught nearly thirty percent of those missed cases.
This means more people can get the right treatment sooner. It helps doctors prioritize who needs the confirmatory test first. It saves time and resources for the hospital.
The tool also predicts who might have worse outcomes. It can tell which patients are at higher risk for heart failure. This helps doctors plan care for the future.
However, the AI is not a final answer. It is a guide for doctors to make decisions. Patients still need a confirmatory scan to prove the disease is there.
What happens when the app launches
The tool is available as a web app for doctors to use. It is designed to help with referrals for testing. This makes the process faster and more accurate.
More research is needed to see how it works in other places. Doctors will need to test it in different hospitals. They must ensure it works for all types of patients.
Regulatory approval is the next step for wider use. The team plans to evaluate the tool further in real-world settings. This ensures it is safe and effective for everyone.
Timely detection is crucial to improve outcomes in patients with cardiac amyloidosis. This tool promises to address diagnostic delays and improve outcomes. It offers hope for better care in the future.